Evolus Scientific Investor Presentation November 2023

Evolus presents clinical and scientific overview of Jeuveau®, its FDA-approved botulinum toxin product for aesthetic use. The presentation discusses market dynamics, clinical trial planning for extra-strength formulations, digital platform strategy, and commercial adoption of the product.